The British Journal of Cardiology

AUGUST 14, 2024

Faculty member Affiliation Professor Amitava Banerjee Professor of Clinical Data Science, Institute of Health Informatics, University College London; Consultant Cardiologist, University College London Hospitals and Barts Health NHS Trust Professor Sir Mark Caulfield Professor of Clinical Pharmacology, Queen Mary Un.

Cardiovascular Disease 52

Cardiovascular Disease Patient Care Innovation Pharmacology 52

DAIC

FEBRUARY 27, 2024

Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment. The prospective, randomized, controlled, multicenter, open-label pivotal clinical study aims to enroll 1,500 patients across up to 100 sites in the United States. 

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

DAIC

APRIL 3, 2024

Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology professionals to advance their practice, patient care and careers. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24”

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103